Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Jun. 30, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 18,300	$ 324,494
Accounts receivable		5,000
Accrued interest receivable		7,521
Loan receivable, other		18,380
Total current assets	18,300	355,395
Property and equipment, less accumulated depreciation of $18,611 and $13,419	17,752	22,944
Notes receivable		350,000
Deposit on building	15,000
Total other assets	32,752	372,944
TOTAL ASSETS	51,052	728,339
CURRENT LIABILITIES
Accounts payable	31,657	15,562
Accrued interest	74,984	47,839
Notes payable-third parties	390,000	387,500
Loans payable, related party	2,250	2,250
Debt discounts		(49,863)
Derivative liability	1,180,680	1,272,799
Total current liabilities	1,679,571	1,676,087
TOTAL LIABILITIES	1,679,571	1,676,087
Commitments and contingencies
Mezzanine Equity:
Common stock to be issued upon conversion of Series L Preferred Stock	2,899,488
Total mezzanine equity	2,899,488
STOCKHOLDERS’ DEFICIENCY
Common stock; 14,991,000,000 shares authorized, $.0001 par value, as of June 30, 2023 and 2022, there are 14,488,440,097 and 13,785,662,319 shares outstanding, respectively	1,448,844	1,378,566
Additional paid- in capital Class A common stock	159,999,238	162,732,907
Additional paid- in capital preferred stock	1,472,285	1,385,113
Common stock to be issued	30,000
Accumulated deficit	(167,478,377)	(166,444,337)
Total stockholders’ deficiency	(4,528,007)	(947,748)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY	51,052	728,339
Series K Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock value
Series L Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock value	$ 3	$ 3